Position in DNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$138,697
New position
Shares Held
22,626
first reported quarter
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026IEQ CAPITAL, LLC holds $245,808,277 across 77 Biotechnology names. DNA ranks #62 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,302 | $60,499,257 | |
| 2 | INCY |
Incyte Corp
|
498,835 | $46,950,350 | |
| 3 | EXEL |
Exelixis, Inc.
|
579,541 | $24,856,513 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
401,610 | $22,686,948 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,175 | $12,134,723 | |
| 6 | QNCX |
Quince Therapeutics, Inc.
|
600,105 | $12,122,121 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
370,481 | $8,061,666 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22,871 | $7,567,327 |
All Filings in DNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $138,697 | 22,626 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||